心脏骤停后炎症反应机制与治疗靶点综述
本文综述了心脏骤停后综合征的炎症与血流动力学机制。许多患者在自主循环恢复后出现系统性缺血再灌注反应,表现为内皮及微血管功能障碍、血管麻痹和免疫失调,导致休克与器官衰竭。文章总结了当前及新兴的靶向辅助治疗策略,并指出免疫调节剂等随机试验结果不一,未来需进行机制表型分析和前瞻性研究。
要点
- 心脏骤停后常出现血管麻痹,表现为全身血管阻力低但心输出量可保留或恢复。
- 目前血流动力学管理仍以支持性治疗为主,核心是达到目标平均动脉压。
- 免疫调节等靶向治疗的随机试验结果混杂,提示存在生物学异质性。
核心结论
- 心脏骤停后综合征中的系统性炎症反应是导致休克和器官衰竭的重要机制。
- 靶向免疫调节和血管活性策略的随机试验结果不一,反映生物学异质性且缺乏表型分层。
研究设计与样本
- 本文为综述,综合了心脏骤停后综合征炎症和血流动力学机制的当代认识。
- 文章梳理了当前及新兴的药理策略,并提出未来研究重点。
主要发现
- 自主循环恢复后可出现内皮和微血管功能障碍、血管麻痹及免疫失调。
- 血流动力学不稳定常为混合性,即使心输出量保留或恢复,全身血管阻力仍低。
- 胃肠道屏障破坏、细胞因子释放、补体激活、一氧化氮-cGMP信号和免疫表型异质性参与其中。
- 免疫调节剂及其他血管活性策略的随机试验结果混杂。
关键数值与推荐
- 血流动力学管理仍以支持性治疗为主,强调达到目标平均动脉压。
- 未来研究需包括机制表型分析、前瞻性生物样本库和前瞻性试验要求。
临床怎么用
- 对心脏骤停后休克患者应注意识别血管麻痹与低全身血管阻力的表现。
- 目前靶向抗炎或免疫调节治疗尚不能作为常规策略,应等待更精确的表型指导。
局限性
- 现有免疫调节剂相关随机试验缺乏充分的表型分层,结果难以推广。
- 当前对心脏骤停后炎症异质性的认识仍有限,缺乏精准管理策略的证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Postcardiac arrest syndrome is a complex multisystem disorder that evolves after return of spontaneous circulation and remains a major determinant of morbidity and mortality following out-of-hospital cardiac arrest. Beyond anoxic brain injury and transient myocardial dysfunction, many patients develop a systemic ischemia/reperfusion response with endothelial and microvascular dysfunction, vasoplegia, and immune dysregulation-features that contribute to shock and organ failure. Hemodynamic instability is often mixed with low systemic vascular resistance despite preserved or recovering cardiac output, but management is still largely supportive and centered on achieving a target mean arterial pressure. An increasing understanding of the central role of inflammation, including gastrointestinal barrier disruption, cytokine release, complement activation, nitric oxide-cGMP signaling, and immune phenotypic heterogeneity has prompted evaluation of targeted adjunctive therapies. However, randomized trials of immunomodulators and other vasoactive strategies have yielded mixed results, reflecting biological heterogeneity and limited phenotypic stratification. This review synthesizes contemporary understanding of the inflammatory and hemodynamic mechanisms underpinning postcardiac arrest syndrome, examines current and emerging pharmacologic strategies, and highlights priorities for future investigation, including mechanistic phenotyping, prospective biobanking, and prospective trial requirements to guide more precise management strategies in postcardiac arrest care.
引用
- Batchelor, Stub, Donner, et al. The Postcardiac Arrest Inflammatory Response: Mechanisms and Therapeutic Targets. Circulation. 2026. PMID: 42574519. doi:10.1161/CIRCULATIONAHA.126.080096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。